CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma
01-05-2023
-30-04-2028
01-05-2023
-30-04-2028
01-05-2023
-31-10-2026
01-06-2021
-31-05-2025
01-09-2015
-31-12-2018
01-01-2024
-31-12-2026
01-11-2022
-31-10-2025
01-04-2020
-31-03-2025